Elsevier

Thrombosis Research

Volume 200, April 2021, Pages 133-140
Thrombosis Research

Selatogrel, a reversible P2Y12 receptor antagonist, has reduced off-target interference with haemostatic factors in a mouse thrombosis model

https://doi.org/10.1016/j.thromres.2021.01.026Get rights and content
Under a Creative Commons license
open access

Highlights

  • Off-target activity of clopidogrel and ticagrelor destabilized mural platelet thrombi and increased blood loss in mouse.

  • In P2Y12 receptor-deficient mouse, the process of haemostasis was independent of the P2Y12 receptor function.

  • Selatogrel, did not interfere with the process of haemostasis, also not in P2Y12 deficient mouse.

  • Selatogrel, did not destabilize mural platelet aggregates, resulting in an improved blood loss profile.

Abstract

Introduction

Selatogrel is a reversible antagonist of the P2Y12 receptor. In rat thrombosis/haemostasis models, selatogrel was associated with lower blood loss than clopidogrel or ticagrelor at equivalent anti-thrombotic effect.

Material and methods

We sought to elucidate the mechanism underlying the observed differences in blood loss, using real-time intravital microscopy in mouse.

Results

Selatogrel, ticagrelor and clopidogrel dose-dependently inhibited laser-induced platelet thrombus formation. At maximal antithrombotic effect, only small mural platelets aggregates, corresponding to hemostatic seals, were present. The phenotype of these hemostatic seals was dependent on the type of P2Y12 receptor antagonist. In the presence of clopidogrel and ticagrelor, detachment of platelets from the hemostatic seals was increased, indicative of reduced stability. In contrast, in the presence of selatogrel, platelet detachment was not increased. Moreover, equivalent antithrombotic dosing regimens of ticagrelor and clopidogrel reduced laser-induced calcium mobilization in the endothelium, restricted neutrophil adhesion and subsequent fibrin formation and thus reduced fibrin-mediated stabilization of the hemostatic seals. The effects of ticagrelor were also observed in P2Y12 receptor deficient mice, indicating that the effects are off-target and independent of the P2Y12 receptor. In contrast, selatogrel did not interfere with these elements of haemostasis in wild-type or in P2Y12 receptor deficient mice.

Conclusion

In the presence of selatogrel the stability of hemostatic seals was unperturbed, translating to an improved blood loss profile. Our data suggest that the mechanism underlying the differences in blood loss profiles of P2Y12 receptor antagonists is by off-target interference with endothelial activation, neutrophil function and thus, fibrin-mediated stabilization of haemostatic seals.

Keywords

Haemostasis
Platelets
P2Y12 receptor antagonist
Thrombosis

Cited by (0)